Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

AVBP Stock Latest News

Company AnnouncementsArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment

11d ago

AVBP

PremiumCompany Announcements

ArriVent BioPharma’s Phase 3 Study on Firmonertinib: A Potential Game-Changer in NSCLC Treatment

12d ago

AVBP

PremiumThe Fly

ArriVent Biopharma appoints Brent Rice as chief commercial officer

2M ago

AUTL

AVBP

PremiumMarket News

3 Best Stocks to Buy Now, 9/10/2025, According to Top Analysts

2M ago

AVBP

NVDA

PremiumRatings

ArriVent BioPharma Buy Rating: Strong Clinical Data and Strategic Positioning Highlight Potential

2M ago

AVBP

PremiumRatingsPromising Market Position and Strong Clinical Results Lead to Buy Rating for ArriVent BioPharma, Inc.

2M ago

AVBP

Premium

Company Announcements

ArriVent BioPharma Announces Promising Phase 1b Study Results

2M ago

AVBP

ArriVent Biopharma presents proof-of-concept data from Phase 1b FURTHER trial

Premium

The Fly

ArriVent Biopharma presents proof-of-concept data from Phase 1b FURTHER trial

2M ago

AVBP

PremiumRatings

ArriVent BioPharma, Inc.: Promising Future with Strong Financials and Key Data Releases Justifying Buy Rating

3M ago

AVBP

PremiumThe Fly

Cooperman’s Omega bought Atlas Energy and ArriVent in Q2

3M ago

APO

PremiumThe Fly

ArriVent Biopharma price target raised to $42 from $40 at H.C. Wainwright

3M ago

AVBP

PremiumThe Fly

ArriVent Biopharma price target lowered to $33 from $40 at Citi

3M ago

AVBP

PremiumCompany AnnouncementsArriVent BioPharma Advances Cancer Therapeutics Pipeline

3M ago

AVBP

Premium

Ratings

Positive Growth Trajectory and Buy Rating for ArriVent BioPharma, Inc. Driven by Promising Clinical Data and Strategic Development

3M ago

AVBP

ArriVent Biopharma reports Q2 EPS (90c), consensus (71c)

Premium

The Fly

ArriVent Biopharma reports Q2 EPS (90c), consensus (71c)

3M ago

AVBP

PremiumThe Fly

ArriVent Biopharma sees cash runway into mid-2027

3M ago

AVBP

PremiumPre-Earnings

ArriVent BioPharma, Inc. (AVBP) Q2 Earnings Cheat Sheet

3M ago

AVBP

PremiumRatings

ArriVent BioPharma Positioned for Success: Buy Rating on Strong Phase 3 Prospects and Financial Health

3M ago

AVBP

PremiumThe Fly

ArriVent Biopharma management to meet with Oppenheimer

3M ago

AVBP

PremiumRatingsArriVent BioPharma’s Promising Clinical Trials and Strategic Plans Drive Buy Rating with $40 Price Target

4M ago

AVBP

Premium

Ratings

Buy Rating for ArriVent BioPharma: Promising Potential of Lead Candidate and Solid Financial Position

4M ago

AVBP

Premium

Company Announcements

ArriVent BioPharma Announces Phase 3 Trial Data Release

4M ago

AVBP

AVBP Stock Latest News

Trending

Indices

Stocks

ETFs